Angiogenic effects of norplant contraception on endometrial histology and uterine bleeding

Journal of Clinical Endocrinology and Metabolism

Volumn 90, Issue 4, 2005, Pages 2142-2147

  Pritts, Elizabeth A ^a,b   Ryan, Isabelle P ^a   Mueller, Michael D ^a   Lebovic, Dan I ^a   Shifren, Jan L ^a   Zaloudek, Charles J ^a   Korn, Abner P ^a   Darney, Philip D ^a   Taylor, Robert N ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOGENIC FACTOR; CD34 ANTIGEN; LEVONORGESTREL; VASCULOTROPIN;

ADULT; ANGIOGENESIS; ARTICLE; BLOOD VESSEL FUNCTION; CLINICAL ARTICLE; CLUSTER ANALYSIS; DRUG EFFECT; ENDOMETRIUM; ENDOMETRIUM BIOPSY; FEMALE; HUMAN; HYSTEROSCOPY; IMMUNOHISTOCHEMISTRY; INTRAUTERINE CONTRACEPTIVE DEVICE; MENSTRUAL CYCLE; PARACRINE SIGNALING; PRIORITY JOURNAL; PROTEIN EXPRESSION; STROMA CELL; UTERUS BLEEDING; VASCULAR ENDOTHELIUM;

ADULT; CONTRACEPTIVE AGENTS, FEMALE; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; LEVONORGESTREL; MIDDLE AGED; NEOVASCULARIZATION, PHYSIOLOGIC; UTERINE HEMORRHAGE; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 17844375405     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2004-1692     Document Type: Article

References (39)

1. Meckstroth KR, Darney PD 2000 Implantable contraception. Obstet Gynecol Clin North Am 27:781-815
2. Kolakevsky G, Barnhart K 2001 Norplant and other implantable contraceptives. Clin Obstet Gynecol 44:92-100
3. Croxatto HB 2000 Progestin implants. Steroids 65:681-685
4. Rogers PA, Au CL, Affandi B 1993 Endometrial microvascular density during the normal menstrual cycle and following exposure to long-term levonorgestrel. Hum Reprod 8:1396-1404
5. Faundes A, Alvarez-Sanchez F, Brache V, Jimenez E, Tejada AS 1991 Hormonal changes associated with bleeding during low-dose progestogen contraception delivered by Norplant subdermal implants. Adv Contracept 7:85-94
6. Simbar M, Manconi F, Markham R, Hickey M, Fraser IS 2004 A three-dimensional study of endometrial microvessels in women using the contraceptive subdermal levonorgestrel implant system, Norplant. Micron 35:589-595
7. Goodger AM, Rogers PA, Affandi B 1994 Endometrial endothelial cell proliferation in long-term users of subdermal levonorgestrel. Hum Reprod 9:1647-1651
8. Hourihan H, Sheppard B, Belsey E, Brosens I 1991 Endometrial vascular features prior to and following exposure to levonorgestrel. Contraception 43:375-385
9. Rogers PAW 1996 Endometrial vasculature in Norplant users. Hum Reprod 2(Suppl 2):45-50
10. Hickey M, Fraser IS 2002 Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding. Hum Reprod 17:2428-2434
11. Runic R, Schatz F, Wan L, Demopoulos R, Krikun G, Lockwood CJ 2000 Effects of Norplant on endometrial tissue factor expression and blood vessel structure. J Clin Endocrinol Metab 85:3853-3859
12. Hickey M, Dwarte D, Fraser IS 2000 Superficial endometrial vascular fragility in Norplant users and in women with ovulatory dysfunctional uterine bleeding. Hum Reprod 15:1509-1514
13. Lockwood CJ, Kumar P, Krikun G, Kadner S, Dubon P, Critchley H, Schatz F 2004 Effects of thrombin, hypoxia, and steroids on interleukin-8 expression in decidualized human endometrial stromal cells: implications for long-term progestin-only contraceptive-induced bleeding. J Clin Endocrinol Metab 89:1467-1475
14. Darney PD, Taylor RN, Klaisle C, Bottles K, Zaloudek CJ 1996 Serum concentrations of estradiol, progesterone, and levonorgestrel are not determinants of endometrial histology or abnormal bleeding in long-term Norplant implant users. Contraception 53:97-100
15. Smith SK 2001 Regulation of angiogenesis in the endometrium. Trends Endocrinol Metab 12:147-151
16. Rogers PA, Gargett CE 1998 Endometrial angiogenesis. Angiogenesis 2:287-289
17. Lebovic DI, Shifren JL, Ryan IP, Mueller MD, Korn AP, Darney PD, Taylor RN 2000 Ovarian steroid and cytokine modulation of human endometrial angiogenesis. Hum Reprod 15(Suppl 3):67-77
18. Bausero P, Cavaille F, Meduri G, Freitas S, Perrot-Applanat M 1998 Paracrine action of vascular endothelial growth factor in the human endometrium: production and target sites, and hormonal regulation. Angiogenesis 2:167-182
19. Charnock-Jones DS, Macpherson AM, Archer DF, Leslie S, Makkink WK, Sharkey AM, Smith SK 2000 The effect of progestins on vascular endothelial growth factor, oestrogen receptor and progesterone receptor immunoreactivity and endothelial cell density in human endometrium. Hum Reprod 15(Suppl 3):85-95
20. Hyder SM, Huang JC, Nawaz Z, Boettger-Tong H, Makela S, Chiappetta C, Stancel GM 2000 Regulation of vascular endothelial growth factor expression by estrogens and progestins. Environ Health Perspect 108(Suppl 5):785-790
21. Shifren JL, Tseng JF, Zaloudek CJ, Ryan IP, Meng YG, Ferrara N, Jaffe RB, Taylor RN 1996 Ovarian steroid regulation of vascular endothelial growth factor in the human endometrium: implications for angiogenesis during the menstrual cycle and in the pathogenesis of endometriosis. J Clin Endocrinol Metab 81:3112-3118
22. Archer DF, Navarro FJ, Leslie S, Mirkin S 2004 Effects of levonorgestrel, medroxyprogesterone acetate, norethindrone, and 17β-estradiol on vascular endothelial growth factor isomers 121 and 165 in Ishikawa cells. Fertil Steril 81:165-170
23. Schneider MB, Bijur PE, Fisher M, Friedman SB, Toffler CP 2003 Menstrual irregularity in female military cadets: comparison of data utilizing short-term and long-term recall. J Pediatr Adolesc Gynecol 16:89-93
24. Lessey BA, Castelbaum AJ, Sawin SW, Buck CA, Schinnar R, Bilker W, Strom BL 1994 Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 79:643-649
25. Brache V, Alvarez-Sanchez F, Faundes A, Tejada AS, Cochon L 1990 Ovarian endocrine function through five years of continuous treatment with Norplant subdermal contraceptive implants. Contraception 41:169-177
26. Croxatto H, Diaz S, Brandeis A, Pavez M, Johansson ED 1985 Plasma levonorgestrel and progesterone levels in women treated with silastic covered rods containing levonorgestrel. Contraception 31:643-654
27. Lau TM, Affandi B, Rogers PAW 1998 The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium. Mol Hum Reprod 5:57-63
28. Gargett CE, Lederman FL, Lau TM, Taylor TM, Rogers PAW 1999 Lack of correlation between vascular endothelial growth factor production and endothelial cell proliferation in the human endometrium. Hum Reprod 18:2080-2088
29. Hornung D, Lebovic DI, Shifren JL, Vigne JL, Taylor RN 1998 Vectorial secretion of vascular endothelial growth factor by polarized human endometrial epithelial cells. Fertil Steril 69:909-915
30. Nayak NR, Brenner RM 2002 Vascular proliferation and vascular endothelial growth factor expression in the rhesus macaque endometrium. J Clin Endocrinol Metab 87:1845-1855
31. Mueller MD, Lebovic DI, Garrett E, Taylor RN 2000 Neutrophils infiltrating the endometrium express vascular endothelial growth factor: potential role in endometrial angiogenesis. Fertil Steril 74:107-112
32. Gargett CE, Lederman F, Heryanto B, Gambino LS, Rogers PAW 2001 Focal vascular endothelial growth factor correlates with angiogenesis in human endometrium. Role of intravascular neutrophils. Hum Reprod 16: 1065-1075
33. Bond CP, Parry LJ, Samuel CS, Gehring HM, Lederman FL, Rogers PA, Summers RJ 2004 Increased expression of the relaxin receptor (LGR7) in human endometrium during the secretory phase of the menstrual cycle. J Clin Endocrinol Metab 89:3477-3478
34. Mueller MD, Vigne J-L, Pritts EA, Chao V, Dreher E, Taylor RN 2003 Progestins activate vascular endothelial growth factor (VEGF) gene transcription in endometrial adenocarcinoma cells. Fertil Steril 79:386-392
35. d'Arcangues C, Piaggio G, Brache V, Aissa RB, Hazelden C, Massai R, Pinol A, Subakir SB, Su-Juan G, on behalf of the Study Group on Progestogen-Induced Vaginal Bleeding Disturbances 2004 Effectiveness and acceptability of vitamin E and low-dose aspirin, alone or in combination, on Norplant-induced prolonged bleeding. Contraception 70:451-462
36. Krikun G, Sakkas D, Schatz F, Buchwalder L, Hylton D, Tang C, Lockwood CJ 2004 Endometrial angiopoietin expression and modulation by thrombin and steroid hormones: a mechanism for abnormal angiogenesis following long-term progestin-only contraception. Am J Pathol 164:2101-2107
37. Laoag-Fernandez JB, Maruo T, Pakarinen P, Spitz IM, Johansson E 2003 Effects of levonorgestrel-releasing intra-uterine system on the expression of vascular endothelial growth factor and adrenomedullin in the endometrium in adenomyosis. Hum Reprod 18:694-699
38. Hyder SM, Stancel GM 1999 Regulation of angiogenic growth factors in the female reproductive tract by estrogens and progestins. Mol Endocrinol 13:806-811
39. Kerbel R, Folkman J 2002 Clinical translation of angiogenesis inhibitors. Nat Rev Cancer 2:727-739